Express Pharma - Page 188 of 2207 - Express Pharma

Lessons from the Delhi–Agra–Puducherry counterfeit medicine investigation

Immuneel and Arogya Finance launch India’s first zero cost EMI program for Qartemi CAR-T Cell Therapy

The fine line between reform and risk

USFDA lifts clinical hold on Opella’s planned actual use trial to switch Cialis from prescription to OTC

Romaco earns gold-level recognition in the EcoVadis sustainability ratings

Venus Remedies secures EU GMP renewal from Infarmed, Portugal

ACG launches new capsule manufacturing facility in Thailand

Glenmark USA launches Phytonadione Injectable Emulsion USP, 10 mg/mL Single Dose Ampules

Strides gains USFDA approval for Acetaminophen and Ibuprofen Tablets, 125 mg /250 mg

Nadda urges industry, academia collaboration to build better healthcare at Healthcare Summit at IIMA

Immuneel Therapeutics launches Qartemi, a CAR T-cell therapy for Non-Hodgkin’s Lymphoma

Industry leaders share their expectations from Budget 2025-26

Zydus receives USFDA approval to conduct Phase II(b) clinical trial for Usnoflast, a novel oral NLRP3 inflammasome inhibitor in patients with ALS